Lawmakers push for Medicare coverage of Alzheimer’s screening tests

1 hour ago 46

Two lawmakers shared how they have personally been impacted by Alzheimer’s and pushed for bipartisan legislation that would provide Medicare coverage for early blood testing for this disease and other dementias during a Wednesday event hosted by The Hill.

Sen. Kevin Cramer (R-N.D.) and Rep. Nanette Barragán (D-Calif.) are both advocating for the passage of the Alzheimer’s Screening and Prevention (ASAP) Act. 

Cramer reflected on his mother’s battle with Alzheimer’s in a pre-recorded interview shared at “The Promise of Early Intervention: The ASAP Act and A New Look at Life with Alzheimer’s” event, which was sponsored by HealthyWomen. 

“Early diagnosis is better for treatment, for preparation, certainly even for possible cures,” he said. “We’ll get there hopefully soon and well with Alzheimer’s.”

The North Dakota Republican said there was a “financial case” to be made for legislation like the ASAP Act that would cover the costs of early screening measures.

“This is a prudent early investment that can save lots of money in the long run, whether it’s for nursing care to include in home or immersion home, just the preparation for families,” Cramer said. “I think there’s a message that cuts across the broadest of political swaths.”

The ASAP Act, which was introduced last year by Sen. Susan Collins (R-Maine), would authorize the Centers for Medicare and Medicaid Services (CMS) to cover early detection blood tests that have been approved by the Food and Drug Administration (FDA) under Medicare. 

Barragán, who sits on the House Committee on Energy and Commerce’s Health Subcommittee, also expressed her support for Medicare coverage of these tests in an interview with The Hill’s contributing editor Kathleen Koch on Wednesday. 

“Without having a Medicare cover and pay for this, it will be inaccessible to some folks,” she said in a pre-recorded interview shared at the event. 

Barragán noted that the ASAP Act would also authorize CMS to cover new blood tests approved by the FDA, calling this provision a “game changer.”

The Democrat also shared her experience as a caregiver after her mother’s Alzheimer’s diagnosis. 

“It took way too long for somebody to see if she had the symptoms and she was really at risk for Alzheimer’s, and so that’s one of the reasons I’m so excited when I hear about new developments, new tests and making sure everybody has access to new tests, because we should know as early as possible,” Barragán said. 

Read Entire Article